ID: ALA5198778

Max Phase: Preclinical

Molecular Formula: C43H74N4O12

Molecular Weight: 839.08

Associated Items:

Representations

Canonical SMILES:  CCCCC[C@@H]1OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)NC1=O

Standard InChI:  InChI=1S/C43H74N4O12/c1-12-16-20-24-32-36(48)44-28(5)40(52)57-33(25-21-17-13-2)37(49)46(10)30(7)42(54)59-35(27-23-19-15-4)39(51)47(11)31(8)43(55)58-34(26-22-18-14-3)38(50)45(9)29(6)41(53)56-32/h28-35H,12-27H2,1-11H3,(H,44,48)/t28-,29-,30-,31-,32+,33+,34+,35+/m1/s1

Standard InChI Key:  NCNWFFJOZKHMDH-VGGYQFRISA-N

Associated Targets(non-human)

Ryanodine receptor 2 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 839.08Molecular Weight (Monoisotopic): 838.5303AlogP: 5.01#Rotatable Bonds: 16
Polar Surface Area: 195.23Molecular Species: NEUTRALHBA: 12HBD: 1
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.09CX Basic pKa: CX LogP: 6.72CX LogD: 6.72
Aromatic Rings: 0Heavy Atoms: 59QED Weighted: 0.12Np Likeness Score: 0.66

References

1. Smith AN, Thorpe MP, Blackwell DJ, Batiste SM, Hopkins CR, Schley ND, Knollmann BC, Johnston JN..  (2022)  Structure-Activity Relationships for the N-Me- Versus N-H-Amide Modification to Macrocyclic ent-Verticilide Antiarrhythmics.,  13  (11.0): [PMID:36385927] [10.1021/acsmedchemlett.2c00377]

Source